These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hepcidin and Anemia: A Tight Relationship. Pagani A; Nai A; Silvestri L; Camaschella C Front Physiol; 2019; 10():1294. PubMed ID: 31649559 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological Targeting of the Hepcidin/Ferroportin Axis. Sebastiani G; Wilkinson N; Pantopoulos K Front Pharmacol; 2016; 7():160. PubMed ID: 27445804 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis. Hawula ZJ; Wallace DF; Subramaniam VN; Rishi G Pharmaceuticals (Basel); 2019 Nov; 12(4):. PubMed ID: 31775259 [TBL] [Abstract][Full Text] [Related]
5. Liver iron sensing and body iron homeostasis. Wang CY; Babitt JL Blood; 2019 Jan; 133(1):18-29. PubMed ID: 30401708 [TBL] [Abstract][Full Text] [Related]
6. Hepcidin and Iron in Health and Disease. Nemeth E; Ganz T Annu Rev Med; 2023 Jan; 74():261-277. PubMed ID: 35905974 [TBL] [Abstract][Full Text] [Related]
7. Hepcidin and its multiple partners: Complex regulation of iron metabolism in health and disease. Ginzburg YZ Vitam Horm; 2023; 123():249-284. PubMed ID: 37717987 [TBL] [Abstract][Full Text] [Related]
8. [Progress in iron metabolism research]. Kawabata H Rinsho Ketsueki; 2017; 58(10):1864-1871. PubMed ID: 28978826 [TBL] [Abstract][Full Text] [Related]
9. Regulators of hepcidin expression. Roth MP; Meynard D; Coppin H Vitam Horm; 2019; 110():101-129. PubMed ID: 30798807 [TBL] [Abstract][Full Text] [Related]
10. Iron metabolism and iron disorders revisited in the hepcidin era. Camaschella C; Nai A; Silvestri L Haematologica; 2020; 105(2):260-272. PubMed ID: 31949017 [TBL] [Abstract][Full Text] [Related]
11. [Iron metabolism: State of the art]. Beaumont C; Karim Z Rev Med Interne; 2013 Jan; 34(1):17-25. PubMed ID: 22595534 [TBL] [Abstract][Full Text] [Related]
12. Hepcidin and iron disorders: new biology and clinical approaches. Arezes J; Nemeth E Int J Lab Hematol; 2015 May; 37 Suppl 1():92-8. PubMed ID: 25976966 [TBL] [Abstract][Full Text] [Related]
13. Physiological and pathophysiological mechanisms of hepcidin regulation: clinical implications for iron disorders. Xu Y; Alfaro-Magallanes VM; Babitt JL Br J Haematol; 2021 Jun; 193(5):882-893. PubMed ID: 33316086 [TBL] [Abstract][Full Text] [Related]
14. Regulation of hepcidin and iron-overload disease. Lee PL; Beutler E Annu Rev Pathol; 2009; 4():489-515. PubMed ID: 19400694 [TBL] [Abstract][Full Text] [Related]
15. Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic Review. Liu J; Sun B; Yin H; Liu S Medicine (Baltimore); 2016 Apr; 95(14):e3150. PubMed ID: 27057839 [TBL] [Abstract][Full Text] [Related]
16. Hepcidin. Ganz T Rinsho Ketsueki; 2016; 57(10):1913-1917. PubMed ID: 27725588 [TBL] [Abstract][Full Text] [Related]
17. Hepcidin and its role in regulating systemic iron metabolism. Ganz T Hematology Am Soc Hematol Educ Program; 2006; ():29-35, 507. PubMed ID: 17124036 [TBL] [Abstract][Full Text] [Related]
18. Hepcidin and iron metabolism: from laboratory to clinical implications. Franchini M; Montagnana M; Lippi G Clin Chim Acta; 2010 Nov; 411(21-22):1565-9. PubMed ID: 20620132 [TBL] [Abstract][Full Text] [Related]
19. Hepcidin and disorders of iron metabolism. Ganz T; Nemeth E Annu Rev Med; 2011; 62():347-60. PubMed ID: 20887198 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of hepcidin - the master regulator of iron metabolism. Vyoral D; Jiri Petrak Pharmacol Res; 2017 Jan; 115():242-254. PubMed ID: 27867027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]